Author

Yi‐Sheng Liu

Henan UniversityORCID 0000-0002-1085-1947Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Haoran WangiD· 1 shared Jin-Hai WangiD· 1 shared Wanhong ZhangiD· 1 shared Yinghao ZhangiD· 1 shared Yufang Sui· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Haoran WangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 12, 2025

VAMP5 is a novel target for selective inhibition of gliomas with high NDRG4 expression via downregulating PLK1 and beyond

Yinghao Zhang, Yi‐Sheng Liu, Wanhong Zhang…·Yufang Sui

The paper identifies VAMP5 as a therapeutic target for gliomas with high NDRG4 expression, showing it downregulates PLK1 and other genes, with NDRG4 as a predictor of treatment sensitivity.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky